Stocktoria
Microbot Medical Inc. MBOT
Microbot Medical Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $6.3M | $6.6M | $5.7M | $7.7M | $6.2M | $3.4M | $3.0M | $2.5M | $1.1M | -$901,000 |
| SG&A expense | $8.5M | $5.0M | — | — | — | — | — | — | — | — |
| Operating income | -$14.7M | -$11.6M | -$9.9M | -$13.3M | -$11.4M | -$9.1M | -$7.2M | -$7.2M | $5.3M | -$9.6M |
| Interest expense | — | — | — | — | — | — | — | — | $237,000 | $333,000 |
| Income tax | — | — | — | — | — | $0 | $0 | — | — | — |
| Net income | -$13.1M | -$11.4M | -$10.7M | -$13.2M | -$11.3M | -$9.2M | -$7.2M | -$7.3M | -$7.6M | -$9.7M |
| EPS (diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | — | — | — | — | — | — |
| Operating cash flow | -$13.0M | -$8.8M | -$8.5M | -$11.5M | -$9.4M | -$7.3M | -$6.5M | -$5.3M | -$4.9M | -$786,000 |
| Free cash flow | -$13.1M | -$8.9M | -$8.6M | -$11.6M | -$9.4M | -$7.3M | -$6.7M | -$5.5M | -$4.9M | -$811,000 |
| Cash & equivalents | $3.9M | $3.1M | $2.5M | $2.4M | $13.5M | $19.6M | $28.8M | $5.2M | $10.8M | $2.7M |
| Inventory | $584,000 | — | — | — | — | — | — | — | — | — |
| Total assets | $81.5M | $6.0M | $8.3M | $9.5M | $16.8M | $26.3M | $37.1M | $6.1M | $11.0M | $3.4M |
| Total liabilities | $4.0M | $2.5M | $3.8M | $2.2M | $2.4M | $2.0M | $5.6M | $4.8M | $556,000 | $1.2M |
| Shareholders' equity | $77.6M | $3.5M | $4.5M | $7.3M | $14.4M | $24.3M | $31.5M | $1.3M | $10.0M | $1.7M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.